Results 291 to 300 of about 16,339,920 (405)

Glycosylated LGALS3BP is highly secreted by bladder cancer cells and represents a novel urinary disease biomarker

Molecular Oncology, EarlyView.
Urinary LGALS3BP is elevated in bladder cancer patients compared to healthy controls as detected by the 1959 antibody–based ELISA. The antibody shows enhanced reactivity to the high‐mannose glycosylated variant secreted by cancer cells treated with kifunensine (KIF).
Asia Pece, Giulio Lovato, Ilaria Cela, Arianna Mercatelli, Benedetta Ferro, Jussi Nikkola, Sara Pagotto, Tommaso Grottola, Vincenzo De Laurenzi, Rossella Cicchetti, Antonio Marchetti, Luigi Schips, Rossano Lattanzio, Stefano Iacobelli, Emily Capone, Peter Black, Mads Daugaard, Michele Marchioni, Gianluca Sala   +18 more
wiley   +1 more source

CELL CYCLE KINETICS AND DEVELOPMENT OF HYDRA ATTENUATA [PDF]

, 1974
Campbell, R. D., David, Charles N.
core  

Cell-Cycle Therapeutics Come of Age.

Journal of Clinical Oncology, 2017
M. Ingham, G. Schwartz
semanticscholar   +1 more source

Survivin and Aurora Kinase A control cell fate decisions during mitosis

Molecular Oncology, EarlyView.
Aurora A interacts with survivin during mitosis and regulates its centromeric role. Loss of Aurora A activity mislocalises survivin, the CPC and BubR1, leading to disruption of the spindle checkpoint and triggering premature mitotic exit, which we refer to as ‘mitotic slippage’.
Hana Abdelkabir, Shalitha Wickrama Arachchige, Sally P. Wheatley   +2 more
wiley   +1 more source

Erratum: [Corrigendum] UBE2T silencing suppresses proliferation and induces cell cycle arrest and apoptosis in bladder cancer cells. [PDF]

Oncol Lett
Gong YQ, Peng D, Ning XH, Yang XY, Li XS, Zhou LQ, Guo YL.   +6 more
europepmc   +1 more source

Visualizing Spatiotemporal Dynamics of Multicellular Cell-Cycle Progression

Cell, 2008
A. Sakaue-Sawano, H. Kurokawa, T. Morimura, A. Hanyu, H. Hama, Hatsuki Osawa, S. Kashiwagi, K. Fukami, T. Miyata, H. Miyoshi, T. Imamura, M. Ogawa, H. Masai, A. Miyawaki   +13 more
semanticscholar   +1 more source

CDK11 inhibition induces cytoplasmic p21WAF1 splice variant by p53 stabilisation and SF3B1 inactivation

Molecular Oncology, EarlyView.
CDK11 inhibition stabilises the tumour suppressor p53 and triggers the production of an alternative p21WAF1 splice variant p21L, through the inactivation of the spliceosomal protein SF3B1. Unlike the canonical p21WAF1 protein, p21L is localised in the cytoplasm and has reduced cell cycle‐blocking activity.
Radovan Krejcir, Lukasz Arcimowicz, Lucia Martinkova, Vaclav Hrabal, Filip Zavadil Kokas, Tomas Henek, Martina Kucerikova, Ondrej Bonczek, Pavlina Zatloukalova, Lenka Hernychova, Philip J. Coates, Borivoj Vojtesek, David P. Lane   +12 more
wiley   +1 more source

Dynamic modelling of cell cycle arrest through integrated single-cell and mathematical modelling approaches. [PDF]

PLoS Comput Biol
Cortés-Ríos J, Rodriguez-Fernandez M, Sorger PK, Fröhlich F.   +3 more
europepmc   +1 more source

Differential Phosphorylation and Turnover of Nuclear Acidic Proteins during the Cell Cycle of Synchronized HeLa Cells

, 1974
Jonathan Karn, Edward M. Johnson, Giorgio Vidali, Vincent G. Allfrey   +3 more
openalex   +1 more source

PP2A as a master regulator of the cell cycle

Critical reviews in biochemistry and molecular biology, 2016
N. Wlodarchak, Y. Xing
semanticscholar   +1 more source